EuroChem Usolskiy Potash Plant
Russia
EuroChem Usolskiy Potash Plant is the subsidiary enterprise of EuroChem which is developing the Verkhnekamsk deposit of potassium and magnesium salts. The Verkhnekamskoye field located in the Perm Territory is one of the largest in the world. The Usolsky Potash Plant obtained the rights to develop potash ore reserves in the field in the amount of over 2.3 billion tons with an average potassium chloride content of 30.8% with a mine life of 35 years.
Company in the news
Advanced AI integration aims to enhance operational efficiency and reduce error rates.
Increased shipments from Russia and Belarus raise concerns over potential oversupply and pricing stability.
$36 million in storage upgrades aims to improve logistics and reduce reliance on third-party facilities.
Multinationals target Brazil for sustainable agribusiness and energy initiatives.
The Lithuanian fertilizer company Lifosa has been officially removed from the European Union’s sanctions list, with UAB “Valnetas” now overseeing its operations as a temporary administrator.
The company commences extensive geological survey to bolster potash production for upcoming decades.
Marc Hechler takes the helm as CEO, with a focus on managing risks and maintaining operational efficiency in challenging times.
Brazilian farmers appreciate the quality and timely delivery of fertilizers from EuroChem’s latest production complex.
The new facility, which will be built over the next three years, will allow EuroChem to increase its total production capacity of potassium chloride to 4.7 million tons per year.
The new facility is set to become one of the largest fertilizer production centers in Brazil and Latin America.
In focus
Stock quotes
Most read
Events
Live
Europe is falling behind in this field. The concerns 30 years ago was reasonable. Now not so much. We need crops that can survive in a more extreme future climate. Handle droughts and hot weather better. Crops that are less tasty to pests like hogs and deere.
Gene-edited crops set for groundbreaking European trials
